PRECIPIO, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
PRECIPIO, INC. (PRPO) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-30
- PRECIPIO, INC. foreign income tax expense (benefit), continuing operations for fiscal 2025 was $0.00.
- PRECIPIO, INC. foreign income tax expense (benefit), continuing operations for fiscal 2024 was $0.00.
- PRECIPIO, INC. foreign income tax expense (benefit), continuing operations for fiscal 2016 was $0.00.
- PRECIPIO, INC. foreign income tax expense (benefit), continuing operations for fiscal 2015 was $0.00.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2016-12-31 | $0.00 10-K · filed 2017-04-13 | |
| 2015-12-31 | $0.00 10-K · filed 2017-04-13 | |
| 2014-12-31 | $0.00 10-K · filed 2016-04-14 | -$107.00K 10-K · filed 2015-04-15 |
| 2013-12-31 | -$54.00K 10-K · filed 2015-04-15 | |
| 2012-12-31 | $143.00K 10-K · filed 2015-04-15 | |
| 2011-12-31 | $26.00K 10-K · filed 2014-03-27 | |
| 2010-12-31 | $117.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |